A validated high-throughput UHPLC-MS/MS assay for accurate determination of rivaroxaban in plasma sample

Abstract

Rivaroxaban is a novel, selective and potent oral direct factor Xa inhibitor, therapeutically indicated in the treatment of thromboembolic diseases. Like traditional anticoagulants, routine coagulation monitoring of rivaroxaban is not necessary, but important in some clinical circumstances. In this study, a sensitive UHPLC-MS/MS assay for rapid… (More)
DOI: 10.1007/s11239-014-1121-2

8 Figures and Tables

Topics

  • Presentations referencing similar topics